Skip to main content
. 2012 May;67(5):497–502. doi: 10.6061/clinics/2012(05)15

Table 3.

Relative organ weight at termination of treatment with E. platyloba (g % body weight).

Sex Dose mg/kg liver% kidney% Heart% Lung%
Male Control 2.9±0.136 0.76±0.024 0.4±0.072 0.56±0.024
50 3.03±0.21 0.79±0.04 0.378±0.015 0.66±0.04
200 2.86±0.15 0.79±0.066 0.34±0.024 0.71±0.08
500 3.07±0.28 0.83±0.05 0.39±0.055 0.54±0.03
Female Control 4±0.2 0.79±0.1 0.38±0.009 0.59±0.036
50 3.1±0.25 0.822±0. 052 0.41±0.006 0.67±0. 03
200 3.03±0.14 0.831±0.0052 0.37±0.031 063±0.056
500 3.26±0.28 0.88±0.04 0.4±0.032 0.80±0.07*

Data presented as mean±S.E.M. for n =  5. Significantly different from control: *p < 0.05.